"Pfizer has made tens of billions in Paxlovid sales, largely through major government purchases. Pfizer could choose now to support the fight against Covid and ease treatment access by lowering its already inflated prices…"
Sunday, October 22, 2023
Pfizer Spikes Paxlovid Prices to 100 Times Cost of Production
Pfizer recently announced it would increase the U.S. list price of its patented Covid treatment nirmatrelvir-ritonavir (Paxlovid) to $1,390 for a five-day treatment course. Experts at Harvard University have estimated that the cost of producing a five-day course of nirmatrelvir-ritonavir is $13…
Subscribe to:
Post Comments (Atom)
Click Older Posts above to see more.
No comments:
Post a Comment